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Gramicidin channelPhotodynamic tumor-destroying activity of the boronated chlorin e6 derivative BACE (chlorin e6 13(1)-N-{2-[N-
(1-carba-closo-dodecaboran-1-yl)methyl]aminoethyl}amide-15(2), 17(3)-dimethyl ester), previously described
in Moisenovich et al. (2010) PLoS ONE 5(9) e12717, was shown here to be enormously higher than that of
unsubstituted chlorin e6, being supported by the data onmuch higher photocytotoxicity of BACE inM-1 sarcoma
cell culture. To validate membrane damaging effect as the basis of the enhanced tumoricidal activity, BACE was
compared with unsubstituted chlorin e6 in the potency to photosensitize dye leakage from liposomes,
transbilayer lipid ﬂip-ﬂop, inactivation of gramicidin A ionic channels in planar lipidmembranes and erythrocyte
hemolysis. In all the models comprising artiﬁcial and cellular membranes, the photodynamic effect of BACE
exceeded that of chlorin e6. BACE substantially differed from chlorin e6 in the afﬁnity to liposomes and erythrocytes,
as monitored by ﬂuorescence spectroscopy, ﬂow cytometry and centrifugation. The results support the key role of
membrane binding in the photodynamic effect of the boronated chlorin e6 amide.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Photodynamic therapy (PDT), a non-surgical cancer treatment
modality, uses the ability of dyes termed photosensitizers to generate
cell-killing singlet oxygen and other reactive oxygen species. Because
the basis of PDT lies in photosensitized oxidation of lipids, proteins
and/or DNA [1], its efﬁcacy essentially depends on the photosensitizer
ability to absorb light in the tissue transparencywindow and the potencyrin e6 13(1)-N-{2-[N-(1-carba-
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nenko),
ights reserved.to generate singlet oxygen. Chlorin derivatives having an intense absorp-
tion band in the far-red region and a high quantumyield of singlet oxygen
generation generally meet the above requirements and, therefore, are
widely used for design and testing of new photodynamic drugs [2]. One
of the most intriguing and so far unresolved issues is associated with
causes of selective accumulation/retention of the PDT agents inmalignant
tumors and approaches to its improvement. Based on photophysical,
photochemical and pharmacokinetic studies [3–6], the photodynamic
activity of chlorin and bacteriochlorin derivatives, amongwhich several
are clinically used [7–12], can be modulated by varying substituents at
the periphery of the tetrapyrrole ring [13,14]. In particular, chlorin e6
ethylenediamide and pheophorbide a ethanolamide exhibited a higher
light-dependent tumor-destroying potency than unsubstituted chlorin
e6 [15] and pheophorbide a [16], respectively. Signiﬁcantly pronounced
photodynamic suppression of tumor growth was foundwith boronated
chlorin e6 derivatives [17,18]. It is worth noting that synthesis and
examination of carboranyl-containing porphyrins [19,20], phthalo-
cyanines [21,22] and chlorins [17,23–25] were prompted by a prom-
ising opportunity of using these compounds as boron-delivery
agents for anticancer boron neutron capture therapy (BNCT), because
of the selective uptake and persistence in tumor over many normal tis-
sues. In particular, for some boronated chlorin e6 and phthalocyanine
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reported [26,27].
Having revealed high photocytotoxicity of chlorin e6 13(1)-N-{2-[N-
(1-carba-closo-dodecaboran-1-yl) methyl] aminoethyl} amide-15(2),
17(3)-dimethyl ester (boronated chlorin e6 amide, BACE), our previous
study [18] left its basis unclear. According to our data, the quantumyield
of singlet oxygen generation of BACEwas close to that of chlorin e6. The
high photodynamic activity of BACE in vivo was tentatively ascribed to
the increased membrane-penetrating ability of this compound [18].
Here we compared the activity of BACE with that of unsubstituted
chlorin e6 in a variety of membrane systems, ranging from lipid and pro-
tein perturbation in model membranes to erythrocyte photohemolysis
and antitumor activity. Chlorin e6 has long been thoroughly studied as
a photosensitizer, therefore itwould be reasonable to use it as a reference
agent while estimating the photodynamic potency of BACE.2. Materials and methods
2.1. Synthesis of the BACE photosensitizer
Synthesis of the BACE photosensitizerwas described previously [18].
Brieﬂy, we used methylpheophorbide a (1; Fig. S1, Supplementary
material) as the starting compound for preparation of free base boronated
chlorin e6 derivatives. The synthesis proceeded via the formation of
the amide derivative2 obtained after the nucleophilic opening of the exo-
cyclic ring in1with ethylenediamine. Alkylation of amino group in 2with
1-triﬂuoromethanesulfonylmethyl-1-carba-closo-dodecaborate cesium 3
[28,23] in tetrahydrofuran in the presence of N,O-bis(trimethylsilyl)acet-
amide led to chlorin e6 13(1)-N-{2-[N-(1-carba-closo-dodecaboran-1-yl)
methyl]aminoethyl}amide-15(2), 17(3)-dimethyl ester cesium 4. For
biological studies the sodium salt, chlorin e6 13(1)-N-{2-[N-(1-carba-
closo-dodecaboran-1-yl)methyl]aminoethyl}amide-15(2), 17(3)-di-
methyl ester sodium (BACE) was obtained from cesium salt 4 (Fig. S1).
Egg yolk phosphatidylcholine (EggPC), diphytanoylphosphati-
dylcholine (DPhPC), and cholesterol (Chol) were from Avanti polar
lipids (Alabaster, AL). 5,6-Carboxyﬂuorescein (CF) was from Sigma-
Aldrich (St. Louis, MO). Chlorin e6 was obtained from Porphyrin
Products (Logan, UT). 1-Lauroyl-2-(1′pyrenebutyroyl)-sn-glycero-3-
phosphocholine (pyPC) was prepared by Dr. Sergei Kovalchuk from
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian
Academy of Sciences as described in [29].
Liposomes were prepared by evaporation under a stream of nitrogen
of 2% solution of EggPC in chloroform followed by hydrationwith a buffer
solution containing 150 mM NaCl, 10 mM KH2PO4, pH 7.4. The mixture
was vortexed, passed through a cycle of freezing and thawing, and ex-
truded through Nucleopore polycarbonate membranes (0.1-μm pore
size) using an Avanti Mini-Extruder.2.2. Fluorescence spectra and polarization degree
Fluorescence spectra and polarization degree were measured with a
Horiba Jobin Yvon FluoroMax-3 spectroﬂuorometer.2.3. Flip-ﬂop of pyPC on liposomes
The measurement of lipid ﬂip-ﬂop was performed as described
in [30]. To label EggPC/Chol vesicles with synthetic lipid probe
pyPC (1-lauroyl-2-(1′pyrenebutyroyl)-sn-glycero-3-phosphocholine)
exclusively on the outer leaﬂet, 5 μM pyPC dissolved in ethanol was
added to the buffer solution containing liposomes (ﬁnal lipid concentra-
tion 50 μg/ml). Incorporation of pyPC into the outer membrane leaﬂet
was followed bymeasuring the ratio of ﬂuorescence intensities ofmono-
mers and excimers at 395 and 480 nm, respectively. The ﬂuorescence
was excited at 344 nm.2.4. Sensitized photoinactivation of gramicidin-mediated current in
planar bilayers
Bilayer lipidmembranes (BLMs)were formedon a0.55-mmdiameter
hole in a Teﬂon partition separating two compartments of a cell con-
taining aqueous solutions of 100 mM KCl, 10 mM MES, and 10 mM
Tris at pH 7.0. The membrane-forming solutions contained 20 mg
of diphytanoylphosphatidylcholine (DPhPC) in 1 ml of n-decane.
Gramicidin A (gA) was added from stock solutions in ethanol (1 μg/ml)
to the bathing solutions at both sides of the BLM and routinely incubated
for 15 min with constant stirring. Experiments were carried out at room
temperature (24–26 °C). The dyes were added to the bathing solution at
the trans side (the cis side is the front side with respect to the illumina-
tion lamp). The electric current (I) was recorded under voltage-clamp
conditions with a Keithley 428 ampliﬁer, digitized by a LabPC 1200
(National Instruments, Austin, TX) and analyzed using a personal com-
puter with the help of WinWCP Strathclyde Electrophysiology Software
designed by J. Dempster (University of Strathclyde, U.K.). Ag–AgCl elec-
trodes were placed directly into the cell, and a voltage of 50 mV was
applied to BLM. The initial level of the gramicidin-mediated current
amounted to 0.41 ± 0.12 μA in all the experiments. The xenon lamp
was placed at the cis-side of the membrane. Illumination of the bilayer
was performed by single ﬂashes (ﬂash energy of 400 mJ/cm2 and ﬂash
duration of 2 ms). The light was passed through a cutoff ﬁlter (for
wavelengths ≤ 500 nm). In the presence of the photosensitizer, a light
ﬂash is known to decrease the gramicidin-mediated transmembrane
current, I(t) [31]. The latter is a monoexponential function of time:
I(t) = (I0 − I∞)e−t/τ + I∞, where I0, I∞, and τ are the initial current
before illumination, the steady-state current measured after light ex-
posure, and the characteristic time of photoinactivation, respectively. It
has been shown that τ is not related to the rate of photoinactivation, but
rather to the dissociation kinetics of gramicidin dimers [31]. Another
important parameter is the relative amplitude of photoinactivation
α: α = (I0 − I∞) / I0. Because the decrease in the gramicidin-
mediated current is due to the reduction of the number of open
channels, while the single-channel conductance remains unaltered
[32], α is equal to the portion of photoinactivated gramicidin chan-
nels. This parameter allows us to compare the efﬁciency of different
photosensitizers.2.5. Blood collection, preparation of red blood cells and kinetics of hemolysis
Blood was collected from healthy volunteers into tubes containing
EDTA as anticoagulant. Red blood cells (RBCs) were harvested by
centrifugation (1500 ×g for 2 min), the plasma was discarded, and
the erythrocyte pellet was washed thrice with sterile buffered saline.
A 1% (v/v) RBC suspension was made in PBS (l0 mM Na phosphate,
150 mM NaCl, pH 7.4). Several experiments (described in Figs. 4
and 5) were run with mouse erythrocytes. Blood from mice was col-
lected from the saphenous vein as described [33]. The time course of
RBC lysis induced by photodynamic treatment was followed spectro-
photometrically at 650 nm with an Amersham Ultrospec 1100 spec-
trophotometer in a 1-cm cuvette. Human RBCs were suspended at a
concentration of 0.1% in PBS buffer. Initially the A650 valuewas approx-
imately 0.5.2.6. Flow cytometry
RBCs were incubated with 1 μM of the dyes for 15 min, and then
washed with PBS. Initial gating on RBCs was performed according to
light scatter characteristics. The ﬂuorescence of BACE and chlorin e6
was measured with excitation at 641 nm, Em: LP 690 nm on a FACS
Aria SORP (BectonDickinson, San Jose, CA). The collected data contained
at least 20,000 events per gate.
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MouseRBCswere isolated in theHanksmediumHBSS containing 1/10
volume of 0.5 mM EDTA. RBCs were placed on round 24 mm glass
cover slips and were incubated with 1 μM of dyes for 5 min. Digital
images were acquired using anNikon Eclipse Ti-E A1 laser-scanning con-
focal system. The 512 × 512 or 1024 × 1024 pixel confocal images
were recorded with an Apo TIRF 60×/1.49 oil objective. Fluorescence
of photosensitizers was excited with a 642 nm laser, and emission
was recorded with a 663–738 nm band pass ﬁlter. The pinholes for
high-resolution images were set up according to the manufacturer's
instructions. Images were analyzed with the NIS-Element imaging
software.
2.8. Cell culture and cytotoxicity assays
M1 sarcoma cells were isolated by incubating the tumor tissue in the
solution of 0.25% Trypsin–EDTA for 40 min. The resulting cell suspension
was evenly distributed into wells of a 96-well plate placing 1.5–104 cells
in 100 μl per well and incubated for 24 h at 37 °C in the dark in an atmo-
sphere containing 6.1% CO2. Then, wells of the same plate were supple-
mented with the compounds under study (100 μl per well) at various
concentrations in amediumcontaining10% fetal calf serum. Cellswere in-
cubated with the compounds for 1 h at 37 °C in an atmosphere contain-
ing 6.1% CO2. After the incubation, cells were irradiated for 30 min by
using a source of monochromatic light with a wavelength of 633 nm.
Then the cells were incubated in the dark for 48 h at 37 °C in an atmo-
sphere containing 6.1% CO2. Then the medium with the compounds was
removed and 100 μl of 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) was added to each well at a concentration of
0.5 mg/ml and incubated for 24 h at 37 °C. The pellet was dissolved
in 200 μl dimethyl sulfoxide (DMSO). Colorimetric measurements
were performed with Labsystem Multiscan plus plate reader at
540 nm. The optical density was directly proportional to the number
of living cells.
Chlorin e6 and BACE were dissolved to obtain 5 mM stock solu-
tions in dimethyl sulfoxide, and serial dilutions were made immedi-
ately before the experiments. The cells were incubated with the dyes
in a 96-well plate for 1 h in the dark. Then cells were illuminated for
10 min using a monochromatic light source (Lebedev Institute of
Physics, Moscow; λ = 650 nm, light energy density = 200 J/cm2)
followed by incubation in fresh medium for 48 h. Then 3-(4,5
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was
added for additional 2 h, and the formation of formazan (MTT test
[34]) was detected by the absorbance at 540 nm using a Multiscan
Plus reader (LabSystems).
2.9. Animals and in vivo PDT
Female rats weighing 180–200 g were used in the experiments.
Sarcoma M1 (a 0.2-g piece of tumor tissue) was inoculated subcuta-
neously into the left thigh. After the tumor nodules were reached,
5 mm in diameter, the animals were divided into 3 cohorts (10 an-
imals per group). Rats in group 1 were injected with PBS, followed
by light illumination in the absence of photosensitizers. Rats in
groups 2–3 were injected with 2.5 mg/kg of either chlorin e6 or
BACE, respectively, followed by light illumination. PBS or photosen-
sitizers were administered i.p. In the preliminary experiments we
found that the maximal accumulation of BACE in the tumors was
detectable 1.5 h after i.p. injection. Therefore, we used a 1.5-h
drug-light interval (i.e., the time between drug injection and
tumor illumination). Hair around the tumor was epilated prior to il-
lumination. PDT was performed with the laser beam source Atcus-2
(Semi-Conductor Devices, St. Petersburg, Russian Federation,
λ = 661 nm, light energy density = 300 mJ/cm2). The tumor size was
measured immediately before illumination and at 3, 7, 14 and 21 dayspost illumination. The volume V (cm3) of the tumor was calculated
using the equation:
VT ¼
1
6
π d1  d2  d3
where d1, d2 and d3 are perpendicular diameters (cm) of the tumormass.
PDT effectiveness was evaluated using a parameter of tumor volume
divided by initial volume (V0), i.e. VT − V0/V0. Tumor-bearing animals
in groups 1–4 were sacriﬁced by day 14 after PDT. Animals in groups
5–6 were monitored for 60 days post PDT.
For histological examination, tumors of the control and experimental
animalswere isolated by using thiopental anesthesia (sodium thiopental,
0.1% solution in a dose of 0.25 ml/100 g body weight) together with the
surrounding soft tissues. The tumors were cut in the proximal–distal
direction, ﬁxed in 10% neutralized formalin solution, dehydratedwith in-
creasing concentrations of ethanol and acetone, and then embedded in
parafﬁn (Histomix, BioVitrum, Russia). The 5-μm histological sections
were stainedwithhematoxylin andeosin and examinedwithmicroscope
“Olympus CX41”.
2.10. Ethics
The verbal informed consent was obtained from all participants in-
volved in this study. The written consent was not necessary since all
participants worked as a multidisciplinary group and openly shared
their results on a regular basis, from the study planning to the ﬁnalized
manuscript. The research involving laboratory mice and rats has been
approved by the Institutional Review Board at Medical Radiological Re-
search Center, Obninsk where the animals were hosted and all animal
experiments were performed. No speciﬁc approval was required for
this particular study since in this institution the experiments with
small laboratory animals were performed under the guidance of the
Ministry of Health and Social Development of Russian Federation, docu-
ment no 755 issued on 12.08.1977, and the Declaration of Helsinki of
World Medical Association (2000).
3. Results
3.1. Comparison of the antitumor effect of BACE and chlorin e6 on rat M-1
sarcoma
It was shown in our previous work that BACE exhibited pronounced
antitumor activity upon photodynamic treatment [18]. Here we com-
pared the activity of BACEwith that of chlorin e6. After the tumor nodules
reached ~6–8 mm in diameter, the animals were divided into 3 cohorts
(10 animals per group): rats were injected with 10 μg/kg BACE, chlorin
e6, and equivalent volume of buffer saline as a control. After illumination
with red light the tumor volumewasmeasured at time intervals indicated
in Fig. 1. Tumor volumes were normalized to their initial levels as de-
scribed in Materials and methods. Fig. 1 shows that chlorin e6 slowed
down the tumor growth while BACE blocked the growth at the same
dosage. Actually, animals treated with BACE exhibited gradual shrinkage
of the tumors after PDT [18].
To analyze the increased activity of BACE in vivo, histological sections
were prepared from tumors subjected or not to PDT. Figs. S2–S4 display
typical sections of a 5-day control (unilluminated) tumor (Fig. S2), a
5-day photodynamically treated tumor (Fig. S3) and a tumor remaining
21 days after PDT (Fig. S4). According to Fig. S2, a solid part of the control
tumor was composed of polymorphic cells having weakly basophilic
cytoplasm and a large nucleus with dispersed chromatin and a large
nucleolus, mitotic ﬁgures and apoptotic bodies were present in the
tumor cells. A section of the tumor subjected to PDT (Fig. S3) shows
that a superﬁcial part of the tumor parenchymawas composed of cellular
elements having densely eosinophilic cytoplasm and a small nucleus
with a poorly discernible nucleolus, and mitotic ﬁgures were observed
control
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Fig. 1. Comparison of BACE and chlorin e6 as antitumor photosensitizers. Rats bearing s.c.
transplant of M-1 sarcoma were injected i.p. with PBS or 2.5 mg/kg of BACE or chlorin e6.
Ninety minutes after injection the tumors were illuminated with red light (see Materials
and methods). The tumor volume was measured at indicated time intervals.
illumination 5 minA
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site of the tumor. The remainder of the tumor was located directly
beneath the scab and partially inside the skin microﬁstula. According to
Fig. S4, the parenchyma consisted of disintegrating tumor cells having
densely eosinophilic cytoplasm and a nucleuswith condensed chromatin.
A substantial fraction of cells showed hallmarks of necrosis and apoptosis,
and numerous apoptotic bodies were seen. The parenchyma was inﬁl-
trated by lymphocytes and polymorphonuclear leukocytes (Fig. S4).
Thus, total necrosis along with partial or complete regression of the
tumor was observed 21 days after PDT. Concomitantly, there was focal
necrosis of surrounding soft tissue with immune cell inﬁltration and re-
placement of necrotic tissue with ﬁbrous growths. Besides, there was a
partial recovery of nerve ﬁbers and blood vessels with mild symptoms
of edema and hemodynamic instability in the irradiated region.A650 = 0.3
T1/2
2 nM chlorin e6
2 nM BACE
40 nM chlorin e6
Δ3.2. Cytotoxicity of BACE and chlorin e6 upon light exposure
Fig. 2 shows survival of sarcomaM-1 cell culture after light exposure
in the presence of BACE and chlorin e6 as determined by the MTT test.
The photocytotoxicity of BACE exceeded many-fold that of chlorin
e6 at doses of 0.03–0.3 μM. No growth retardation or cell death was re-
corded upon the same treatment in the dark.control
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Fig. 2. Viability of culturedM-1 sarcoma cells according to theMTT test after photodynamic
treatment with appropriate concentration of BACE or chlorin e6. Experiments were
performed 3 times and 3 wells per each concentration were analyzed.3.3. Photohemolysis of erythrocytes
To support the idea of cellular membrane being one of the major
targets for photodynamic action sensitized by BACE and chlorin e6, we
performed a comparative study of erythrocyte photohemolysis. Illumi-
nation of human erythrocyte suspension at pH 7.2 (Fig. 3A) in the pres-
ence of the BACE at a concentration of 2 nM brought about erythrocyte
hemolysis, as evidenced by a decrease in light scattering with t1/2 about
2 min. By contrast, no photohemolysis was observed with chlorin e6 at
the same concentration (black curve), and the comparable photody-
namic effect was achieved only at concentrations higher than 40 nM
(green curve). The сoncentration dependence of t1/2 for chlorin e6
was shifted substantially towards higher concentrations, compared to
that for BACE (Fig. 3B). Therefore, BACE appeared to be amuchmore po-
tent photosensitizer for erythrocyte hemolysis than chlorin e6. Earlier
Gurinovich et al. [35] have shown that chlorin e6 ethylenediamide is
more effective in sensitizing erythrocyte photohemolysis than chlorin e6.3.4. Photohemolysis and photosensitizer binding
A large difference in BACE and chlorin e6 binding to mouse erythro-
cytes was demonstrated by ﬂow cytometry (Fig. 4). The maximum in
brightness histogram was shifted to the right with BACE compared to
chlorin e6. In these experiments erythrocytes were incubated with the
dyes for 15 min before centrifugation, then resuspended in the buffer so-
lution and detected after 45 min. The results showed that BACE binds
more effectively to erythrocyte membranes, than chlorin e6, and thus
there is a correlation between photohemolytic activity and membrane
binding. Similar correlation was earlier obtained for chlorin derivatives
in [15] and [36], and for bacteriochlorin derivatives in [37].Concentration (nM)
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Fig. 3. Photohemolysis of human erythrocytes in the presence of BACE and chlorin e6.
A. Time course of a change in absorbance at 650 nm after irradiation with red light. B. The
dependence of photohemolysis half-time on the concentration of BACE and chlorin e6.
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Fig. 4. Flow cytometry analysis of ﬂuorescence emission of mouse red blood cells stained
with BACE or chlorin e6. RBCs were incubated with 1 μM of the dyes for 15 min, washed
with PBS and counted after 45 min.
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Fig. 5 displays a typical micrograph of a mouse erythrocyte showing
distribution of BACE (А) and chlorin е6 (B) ﬂuorescence. It is seen that
BACE was associated predominantly with plasma membrane, whereas
a major portion of chlorin e6 ﬂuorescence originated from cytoplasm.
Transmission light images show that in the case of chlorin e6, some
erythrocytes changed their shape in a way resembling echinocyte
transformation.A
C
Fig. 5. Intracellular distribution of BACE (A) and chlorin e6 (B) in mouse red blood cells (left tw
1 μM of the dyes for 5 min, washed with PBS and imaged.Images of the time series of successive scans obtained with the con-
focal microscope revealed a substantial difference in photocytotoxicity
between BACE and chlorin e6. With BACE (1 μM), destruction of eryth-
rocytes was observed in a 3–4-fold shorter time interval, than with
chlorin e6 at the same concentration under similar conditions of scanning.
Remarkably, the destruction manifested itself as abrupt disappearance of
cellular structure.3.6. Lipid ﬂip-ﬂop
As shown earlier in our lab, photodynamic treatment of bilayer
membranes containing unsaturated lipids facilitated ﬂip-ﬂop of lipid
molecules from one monolayer to another [38]. To follow lipid ﬂip-ﬂop,
we tracked the evolution of the ratio of excimer/monomer ﬂuorescence
intensities (IE/IM) of pyrene-labeled phosphatidylcholine (pyPC), similar
to our previous study [38]. If added to water solution, pyPC inserts solely
into an outer monolayer of a liposome membrane, and induction of
ﬂip-ﬂop leads to redistribution of the labeled lipid between the two
monolayers, manifesting itself in a reduction of the IE/IM ratio due to a
decrease in a local pyPC concentration [30]. Fig. 6 shows time courses
of pyPC ﬂip-ﬂop initiated by photodynamic treatment of liposomes
with BACE or chlorin e6. A rather fast (on a minute scale) decrease in
ﬂuorescence of pyPC excimers paralleled by an increase in ﬂuorescence
of pyPC monomers (Fig. 6A), resulting in a drop of the IE/IM ratio
(Fig. 6B), was recorded after exposure of EggPC/Chol liposomes to red
light in the presence of 0.5 μM of the photosensitizers. In the case of
BACE, the ﬂip-ﬂop kinetics was substantially faster, than with chlorin
e6: estimation of the ﬂip-ﬂop half-time from the monoexponential
curve ﬁtting of 3–4 experiments gave the value (Mean ± S.E.) of
165 ± 15 s for BACE and 330 ± 25 s for chlorin e6. In control experi-
ments, practically no change of the IE/IM ratiowas observed after similarB
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1-min exposure to visible light in the presence of 0.5 μM BACE (blue curve), and 0.5 μM
chlorin e6 (green curve). Gray curves are monoexponential ﬁts with characteristic times
147 s (BACE) and 305 s (chlorin e6). Solution was 100 mM NaCl, 10 mM NaH2PO4,
pH 7.4. pyPC concentration was 5 μM. Lipid concentration was 50 μg/ml.
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Fig. 7. Binding of BACE and chlorin e6 to liposomes made from EggPC. A. Dependence of
the degree of ﬂuorescence polarization of BACE and chlorin e6 on lipid concentration.
Emission at 670 nm, and excitation at 650 nm. B. Dependence of the bathochromic shift
of the ﬂuorescence maxima of BACE and chlorin e6 on lipid concentration. Excitation at
407 nm.
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not shown).3.7. Binding of photosensitizers to liposomes
To examine the relationship between photodynamic activity and
photosensitizer binding to liposomes, we performed ﬂuorescence polari-
zation and spectral measurements. As seen from Fig. 7A, interaction of
BACEwith EggPC liposomes led to a larger increase in the degree of ﬂuo-
rescence polarization than that of chlorin e6, favoring a highermembrane
afﬁnity of BACE compared to chlorin e6. This conclusion was also sup-
ported by a signiﬁcant difference in the magnitudes of the bathochromic
shift of the ﬂuorescence maxima observed upon interaction of BACE and
chlorin e6 (cf. [39])with EggPC liposomes (Fig. 7B). It isworth noting that
BACE ﬂuorescence intensity depended non-monotonously on liposome
concentration, namely: the addition of liposomes at a low concentration
led to quenching of BACE ﬂuorescence, which was followed by a ﬂuores-
cence increase at higher liposome concentrations (Fig. 8). A similarpattern of the concentration dependence was observed previously for
the interaction of cationic aluminum phthalocyanine with liposomes
[40].
3.8. Photosensitized inactivation of gramicidin channels in planar bilayers
The photodynamic activity of photosensitizers in BLM can be also
evaluated by a very convenient method developed in our laboratory,
which consists in measuring damage to the membrane-active peptide
gramicidin A [31,41,42] that is known to form ionic channels selective
to alkaline metal cations. Illumination of planar BLM with visible light in
the presence of a photosensitizer is known to suppress the gramicidin-
mediated transmembrane current [32,31,41,43]. The photoinactivation
of gramicidin A results from thedamage to its tryptophan residues caused
by reactive oxygen species that are generated upon interaction of excited
photosensitizer molecules with oxygen [32,31,44,45]. It has been shown
that the light-induced decrease in the gramicidin-mediated current is
due to the reduction of the number of open channels, while the single
channel conductance remains unaltered [32]. Therefore, the relative
decrease in the current, α = (I0 − I∞) / I0, induced by illumination is
equal to the damaged portion of gramicidin channels. This parameter en-
ables one to compare the efﬁcacy of different photosensitizers. As seen
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ﬂash of visible light in the presence of BACE led to a decrease in the
gramicidin-mediated transmembrane current of potassium ions, in
agreement with the data obtained previously with different substituted
aluminum and zinc phthalocyanines [32,31,41,40,46–48]. Fig. 9B shows
the dependence of gramicidin photodamage on the concentration of
BACE and chlorin e6 in BLM formed from DPhPC, a saturated lipid not
susceptible itself to photodynamic action. In agreementwith the results
of the liposome experiments (Fig. 6), BACEwas alsomore effective than
chlorin e6 in the gramicidin assay. Noteworthy, in this system the differ-
ence between BACE and chlorin e6 activity was rather modest and be-
came indiscernible at low concentrations of the photosensitizers, in
contrast to amarked difference between efﬁcacies of these agents in pro-
moting damage to unsaturated lipids as measured by photosensitized
leakage of ﬂuorescent dyes from liposomes [18]. This result could be
associated with the dependence of the photosensitizing efﬁciency on
the porphyrin depth in a lipid bilayer [49–51] and the relative location
of target and photosensitizer molecules [52–54]. It could be suggested
that BACE, being more hydrophobic than chlorin e6, resides deeper in a
membrane and thus closer to the location of lipid double bonds, but
further from gramicidin tryptophan residues tending to localize at
water–hydrocarbon core interface [55]. The position of chlorin e6 in
close proximity to tryptophans might explain its rather high efﬁcacy in
sensitizing gramicidin photoinactivation.Concentration, μM
0
10
20
0 1 42 3
chlorin e6α,
 
%
Fig. 9. Sensitized photoinactivation of gramicidin A channels in BLM formed from DPhPC
in the presence of BACE and chlorin e6. A. The time course of the decrease in the
gramicidin-mediated current (I) with respect to initial current (I0) across a planar lipid
membrane as a result of illumination with a ﬂash of visible light (marked by an arrow).
Black curve was a control without a photosensitizer, blue curve was obtained with
0.5 μM BACE, and green curve with 0.5 μM chlorin e6. B. Concentration dependence of
the decrease in the gramicidin-mediated current across a planar lipid membrane as a re-
sult of photodynamic action. The solution was 100 mM KCl, 10 mM Tris, pH 7.4.4. Discussion
In our previous studywe demonstrated a remarkable potency of the
boronated chlorin e6 derivative BACE as an antitumor photosensitizer
[18]. It was suggested that photoactivation of BACE triggered intracellular
ROS generation followed by rapid (within the initial minutes after illumi-
nation) damage ofmultiplemembrane organelles, leading to cell necrosis.
The membrane photodamage and necrosis required nanomolar-to-
submicromolar concentrations of the novel photosensitizer. The mecha-
nism of the high photodynamic activity of BACE remained unclear.
According to our data, the quantum yield of singlet oxygen generation
of BACEwas close to that of chlorin e6, whereas the electric current relax-
ation experiments revealed the remarkably high ability of BACE toperme-
ate through the BLM. Therefore, membrane penetrativity was suggested
to account for the enhanced photodynamic activity of BACE [18], although
800 Y.N. Antonenko et al. / Biochimica et Biophysica Acta 1838 (2014) 793–801the relaxation technique did not allow us to monitor membrane translo-
cation of unsubstituted chlorin e6. Noteworthy, rather diverse data on the
ability of chlorins to cross lipid membranes were obtained in different
laboratories [39,56–59]. According to earlier studies, methyl esters of
chlorin e6 and bacteriochlorin exhibit higher afﬁnity to liposomes [35]
and erythrocytes [36,37], as compared to the parent compounds, which
may be associated with an increase in the membrane/water partition co-
efﬁcient upon blocking carboxylic groups by methylation. However, an
increase in hydrophobicity must not obligatorily lead to enhancement
of photodynamic efﬁcacy, because it can reduce water solubility, and
thereby decrease accessibility for cells. In our experiments, the increased
accumulation in cells (Fig. 4) and higher colocalization with the plasma
membrane (Fig. 5) were observed for BACE, as compared to chlorin e6,
in erythrocytes. These results are consistent with the idea that necrosis
being characterized by the loss of plasmamembrane integrity represents
the predominant mechanism of BACE-mediated photodynamic cell
killing. Membrane permeabilization that underlies this mechanism
most probably results from the light-induced peroxidation of unsatu-
rated lipids.
In the present study we scanned the photodynamic efﬁcacy of BACE
with respect to that of unsubstituted chlorin in a series of in vivo and
in vitro models, making the emphasis on the importance of photosensi-
tizer–membrane interaction for the photodynamic potency. In all the ex-
periments described, BACE appeared to cause a larger photoeffect than
unsubstituted chlorin e6. It can be supposed that in vivo, photosensitized
perturbation of different membrane (lipid and protein) components
might synergistically result in a profoundly enhanced photodynamic
potency of BACE.
The photodynamic efﬁcacy of chlorin e6 in cell culture can be signiﬁ-
cantly increased by conjugating the photosensitizer with protein vectors
[60,61], thereby providing its targeted delivery, e.g., to nuclei [61]. In par-
ticular, a modular transporter containing both a receptor-binding ligand
and a nuclear localization sequence represents an elegant, though labori-
ous, example of such a construct [62]. The present study demonstrates an
alternative way of multiple enhancement of chlorin e6 efﬁcacy based
upon linking the photosensitizer to membranotropic boron clusters
which switches the primary target of the photodynamic damage from
DNA to cell membranes. In this case selectivity of tumor damage could
be achieved via directed illumination and preferential accumulation/
retention of photosensitizers in tumor tissues due to impaired lymphatic
drainage.
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